Clinical Study
Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus
Table 1
General characteristics of the insulin pump group and retinopathy group.
| | | Insulin pump group | Retinopathy group | value |
| | Age (years) | 14.9 ± 2.5 | 17.7 ± 1.4 | 0.057 | | Gender: boys/girls | 12/20 | 5/3 | 0.600 | | Height (cm) | 163 ± 10 | 160 ± 10 | 0.870 | | Body mass (kg) | 58 ± 10 | 66.4 ± 12.7 | 0.080 | | BMI (kg/m2) | 21.6 ± 2.8 | 25.2 ± 3.2 | 0.002 | | SDS-BMI | 0.6 ± 0.9 | 1.3 ± 1.2 | 0.072 | | Diabetes duration (years) | 3.7 ± 3.2 | 11 ± 2.7 | <0.001 | | HbA1c (%) (before pump therapy) | 8.3 ± 1.7 | 9.7 ± 2.1 | 0.057 | | HbA1c (%) (6 months after pump therapy) | 7.9 ± 1.4 | 9.7 ± 2.1 | 0.008 | | Systolic blood pressure (mmHg) | 115 ± 7 | 133 ± 18 | <0.001 | | Diastolic blood pressure (mmHg) | 69 ± 6 | 76 ± 10 | 0.020 | | Total cholesterol (mg/dL) | 163 ± 27 | 179 ± 33 | 0.159 | | LDL-cholesterol (mg/dL) | 82 ± 21 | 105 ± 22 | 0.011 | | HDL-cholesterol (mg/dL) | 62 ± 12 | 47 ± 7 | 0.003 | | Triglicerides (mg/dL) | 72 ± 21 | 129 ± 64 | <0.001 |
|
|
